Bing

SEARCH HISTORY

has withdrawn its bid to acquire Mylan ( MYL) Monday morning, after Teva agreed to acquire the generics business from Allergan ( AGN). Mylan has gapped open sharply lower this morning and is now down 9.02 at $56.93 on above average volume. The …
NASDAQ · 7/27/2015
Mr. Vigodman added that Teva will drop its pursuit of rival Mylan NV (NASDAQ:MYL), which it had proposed to buy on April 21. Overall, the news shot the stock up as Teva shares rallied 16% in trading on July 27 …
Investopedia · 7/28/2015
Teva
What: Shares of the specialty and generic drugmaker Mylan (NASDAQ:MYL) fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) dropped its $40 billion hostile takeover bid. Instead, Teva has decided to …
The Motley Fool · 7/27/2015
CHICAGO, July 29, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PANW, XON, FEYE, MYL and KITE. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
Financial Content · 1 day ago
European stocks are falling today as investors cautiously eye the ... Inc (ALK), Weibo Corporation (WB) and Mylan N.V. (MYL) are down. [InvestorsKeyhole, various news and data sources]
Market Intelligence Center · 7/27/2015
Chinese stocks
Those stocks combine for almost 6% of PPH’s weight. In April, Mylan (MYL) offered to acquire Israeli rival Perrigo (PRGO) with Perrigo rebuffing that and a second offer from Mylan. That could send Mylan shopping …
Yahoo Finance · 2 hours ago
Pharma Takeover Candidates
Trader disclosure: On July 28, 2015, the following stocks and commodities mentioned or intended to ... GPS, IBB, JPM, KORS, M, MYL, PFE, SUNE, URI, XBI, KORS call spreads, SUNE call spreads, KORS puts, her …
CNBC · ByStephanie Landsman · 1 day ago
Karen Finerman
Teva's and Allergan's stocks jumped to new highs while Mylan's dropped 14.5% to 56.35. At the same time, Teva abandoned its attempt to acquire generic-drug titan Mylan (NASDAQ:MYL), which had been resisting …
Investors Business Daily · ByAmy Reeves · 7/27/2015
Teva
In addition, 480 stocks hit 52-week lows on the New York Stock Exchange ... giving up on its bid to buy Mylan <MYL.O>. Allergan rose 6.09 percent while Mylan fell 14.51 percent. Fiat Chrysler <FCAU.N> fell 4.88 …
Yahoo News · 7/27/2015
The stock will equate to roughly 10% of the company's outstanding ... it simultaneously announced that it was withdrawing its bid for rival generics drug maker Mylan (NASDAQ:MYL). At the end of the day Teva management probably realized that they had ...
Seeking Alpha · 7/27/2015

Mylan

Company
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters …
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters in Hatfield, Hertfordshire in the United Kingdom. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. Mylan now has approximately 30,000 employees, more than 1,000 separate products, and serves customers in more than 150 countries and territories. Mylan has a global manufacturing output of more than 45 billion doses.
Data from: Wikipedia · Freebase